Prof. Dr. Michael Sticherling

Professur für Dermatologie

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study (2018) Kampylafka E, D'Oliveira I, Linz C, Lerchen V, Stemmler F, Simon D, Englbrecht M, et al. Journal article Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers? (2018) Sticherling M Journal article Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare) (2018) Schaarschmidt ML, Herr RM, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK Journal article Impairment of gustatory and olfactory senses in plaque psoriasis (2017) Rueter P, Gruenthaler V, Zopf Y, Sticherling M Conference contribution Doxycycline versus Prednisolone for the initial Treatment of bullous Pemphigoids: a pragmatic prospective randomized Study (2017) Schmidt E, Benoit S, Ehrchen J, Glaeser R, Guenther C, Steinbrink K, Sticherling M, et al. Conference contribution Fumaric Acid Esters and TNF alpha Inhibitors - Do they affect the Fertility of male Patients with Psoriasis? (2017) Heppt F, Colsmann A, Maronna A, Uslu U, Heppt M, Kiesewetter F, Sticherling M Conference contribution Fumaric Acid Esters: Patient Characteristics and Duration of Therapy from the PsoBest German Psoriasis Registry (2017) Augustin M, Reich K, Spehr C, Rustenbach SJ, Mrowietz U, Radtke MA, Wilsman-Theis D, et al. Conference contribution Hydradenitis suppurativa - new exploration on the famous Disease (2017) Oetterich K, Heppt F, Sticherling M Conference contribution Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatment (2017) Von Kiedrowski R, Korber A, Kraehn-Senftleben G, Sticherling M, Lange L, Bachhuber T, Kasparek TR, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without previous Systemic Therapy for Improvement of Skin Symptoms: PASI and IGA mod. 2011-Results of the PRIME Study (2017) Reich K, Mrowietz U, Augustin M, Thaci D, Kneidl J, Hentschke C, Simang M, et al. Conference contribution